Finance

Lists
424870:KOSDAQ
ImmuneOncia Therapeutics Inc
₩3,110.00
+1.97%
(+60.00) 1D
Oct 19, 3:30:28 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 424870...
Open
₩2,950
High
₩3,135
Low
₩2,950
Mkt. cap
284.26B
Avg. vol.
1.04M
Volume
201.96K
52-wk high
₩14,964
52-wk low
₩2,300
EPS
-₩380
Shares outstanding
91.40M
No. of employees
26
Open
₩2,950
High
₩3,135
Low
₩2,950
Mkt. cap
284.26B
Avg. vol.
1.04M
Volume
201.96K
52-wk high
₩14,964
52-wk low
₩2,300
EPS
-₩380
Shares outstanding
91.40M
No. of employees
26
News stories
From web sources and news partners
About ImmuneOncia Therapeutics Inc
CEO-
Employees26
Founded2016
Headquarters-
SectorBiotechnology
Websiteimmuneoncia.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
4.07M
2.88M
3.50M
3.94M
Cost of revenue
4.07M
2.88M
3.50M
3.94M
Research and development expenses
9.29B
8.31B
4.51B
2.85B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.11B
1.06B
1.04B
1.24B
Operating expense
10.59B
9.56B
5.75B
4.27B
Total operating expenses
10.60B
9.57B
5.75B
4.27B
Operating income
-10.60B
-9.57B
-5.75B
-4.27B
Other non operating income
-35.53M
-15.34M
-807.92K
-1.09M
EBT including unusual items
-10.37B
-9.41B
-5.62B
-3.90B
EBT excluding unusual items
-10.37B
-9.41B
-5.62B
-3.90B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2.54M
6.36M
17.97M
4.66M
Net income
-10.37B
-9.41B
-5.62B
-3.90B
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
245.26M
206.69M
162.59M
416.30M
Interest expense
-1.28M
-1.21M
-995.00K
-779.00K
Net interest expenses
243.97M
205.48M
161.60M
415.52M
Depreciation and amortization charges
40.98M
40.33M
38.52M
37.32M
EBITDA
-10.33B
-9.34B
-5.53B
-4.06B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps